| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |